OLR1 and systemic lupus erythematosus: Moreover, Dectin3 promoted the expression of LOX-1 on M-MDSCs to increase the Th17/Treg cell imbalance, indicating that LOX-1+ M-MDSCs could be regarded as new target cells for treating lupus.